16S rRNA Metabarcoding Used to Identify the Etiology of Infective Endocarditis Agents

The aim of the study was to estimate the efficiency of identifying bacterial agents in native cardiac valves affected by infective endocarditis using 16S rRNA metabarcoding.

Materials and Methods. The study material involved 20 native cardiac valve samples from 16 patients. Sequencing was carried out in the Center for Collective Use “Genomics” (Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Russia) on a sequenator MiSeq (Illumina, USA) using MiSeq Reagent Kit v3 (2×300 bp; Illumina, USA).

Results. The study revealed major microorganisms (their portion in the sample under study was over 5% from all identified bacterial agents) belonging to Streptococcus (40% of all valves studied), Sphingomonas (35%), Pseudomonas (35%), Roseateles (25%), Phyllobacterium (25%), and Enterococcus (15%). Moreover, the studied valves were found to have rare cases of Ralstonia pickettii, as well as Bacillus and Klebsiella representatives.

Conclusion. The findings demonstrated the efficiency of 16S rRNA metabarcoding in identifying bacterial agents compared to routine noninvasive diagnostic methods. Native cardiac valves isolated from the patients with infective endocarditis were characterized by numerous opportunistic pathogenic bacteria in negative blood cultures.

1. Li M., Kim J.B., Sastry B.K.S., Chen M. Infective endocarditis. Lancet 2024; 404(10450): 377–392, https://doi.org/10.1016/S0140-6736(24)01098-5.
2. Martínez-Sellés M., Muñoz P. Epidemiology, diagnosis, treatment, and prognosis of infective endocarditis. J Clin Med 2023; 12(17): 5705, https://doi.org/10.3390/jcm12175705.
3. Stasev A.N., Rutkovskaya N.V., Kokorin S.G., Levadin Yu.V. Salmonella endocarditis of mitral valve: clinical observation. Complex Issues of Cardiovascular Diseases 2017; 2: 123–126, https://doi.org/10.17802/2306-1278-2017-2-123-126.
4. Oberbach A., Schlichting N., Feder S., Lehmann S., Kullnick Y., Buschmann T., Blumert C., Horn F., Neuhaus J., Neujahr R., Bagaev E., Hagl C., Pichlmaier M., Rodloff A.C., Gräber S., Kirsch K., Sandri M., Kumbhari V., Behzadi A., Behzadi A., Correia J.C., Mohr F.W., Friedrich M. New insights into valve-related intramural and intracellular bacterial diversity in infective endocarditis. PLoS One 2017; 12(4): e0175569, https://doi.org/10.1371/journal.pone.0175569.
5. Demin A.A., Kobalava Zh.D., Skopin I.I., Tyurin P.V., Boytsov S.A., Golukhova E.Z., Gordeev M.L., Gudymovich V.D., Demchenko E.A., Drobysheva V.P., Domonova E.A., Drapkina O.M., Zagorodnikova K.A., Irtyuga O.B., Kakhktsyan P.S., Kozlov R.S., Kotova E.O., Medvedev A.P., Muratov R.M., Nikolaevsky E.N., Pisaryuk A.S., Ponomareva E.Yu., Popov D.A., Rakhina S.A., Revishvili A.G., Reznik I.I., Ryzhkova D.S., Safarova A.F., Tazina S.Ya., Chipigina N.S., Shipulina O.Yu., Shlyakhto E.S., Schneider Yu.A., Shostak N.A. Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021. Russian Journal of Cardiology 2022; 27(10): 5233, https://doi.org/10.15829/1560-4071-2022-5233.
6. Kotova E.O., Domonova E.A., Kobalava Z.D., Moiseeva A.Y., Pisaryuk A.S., Silveystrova O.Y., Karaulova J.L., Akimkin V.G. Clinical and diagnostic value of including PCR blood test in the traditional algorithm for identifying causative agents of infective endocarditis: a cohort study of 124 patients. Terapevticheskii arkhiv 2023; 95(1): 23–31, https://doi.org/10.26442/00403660.2023.01.202042.
7. Zeng X., Wu J., Li X., Xiong W., Tang L., Li X., Zhuang J., Yu R., Chen J., Jian X., Lei L. Application of metagenomic next-generation sequencing in the etiological diagnosis of infective endocarditis during the perioperative period of cardiac surgery: a prospective cohort study. Front Cardiovasc Med 2022; 9: 811492, https://doi.org/10.3389/fcvm.2022.811492.
8. Haddad S.F., DeSimone D.C., Chesdachai S., Gerberi D.J., Baddour L.M. Utility of metagenomic next-generation sequencing in infective endocarditis: a systematic review. Antibiotics (Basel) 2022; 11(12): 1798, https://doi.org/10.3390/antibiotics11121798.
9. Burban A., Słupik D., Reda A., Szczerba E., Grabowski M., Kołodzińska A. Novel diagnostic methods for infective endocarditis. Int J Mol Sci 2024; 25(2): 1245, https://doi.org/10.3390/ijms25021245.
10. Martinez-Porchas M., Villalpando-Canchola E., Ortiz Suarez L.E., Vargas-Albores F. How conserved are the conserved 16S-rRNA regions? PeerJ 2017; 5: e3036, https://doi.org/10.7717/peerj.3036.
11. Anton-Vazquez V., Dworakowski R., Cannata A., Amin-Youssef G., Gunning M., Papachristidis A., MacCarthy P., Baghai M., Deshpande R., Khan H., Byrne J., Fife A. 16S rDNA PCR for the aetiological diagnosis of culture-negative infective endocarditis. Infection. 2022;50(1):243-249. doi: https://doi.org/10.1007/s15010-021-01690-x.
12. Fadrosh D.W., Ma B., Gajer P., Sengamalay N., Ott S., Brotman R.M., Ravel J. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2014; 2(1): 6, https://doi.org/10.1186/2049-2618-2-6.
13. Shen W., Le S., Li Y., Hu F. SeqKit: a cross-platform and ultrafast toolkit for FASTA/Q file manipulation. PLoS One 2016; 11(10): e0163962, https://doi.org/10.1371/journal.pone.0163962.
14. https://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
15. Edgar R.C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 2013; 10(10): 996–998, https://doi.org/10.1038/nmeth.2604.
16. Edgar R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26(19): 2460–2461, https://doi.org/10.1093/bioinformatics/btq461.
17. Edgar R.C. UNOISE2: improved error-correction for Illumina 16S and ITS amplicon sequencing. bioRxiv 2016, https://doi.org/10.1101/081257.
18. Edgar R.C. SINTAX: a simple non-Bayesian taxonomy classifier for 16S and ITS sequences. bioRxiv 2016, https://doi.org/10.1101/074161.
19. Wang Q., Garrity G.M., Tiedje J.M., Cole J.R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007; 73(16): 5261–5267, https://doi.org/10.1128/AEM.00062-07.
20. Kouijzer J.J.P., Noordermeer D.J., van Leeuwen W.J., Verkaik N.J., Lattwein K.R. Native valve, prosthetic valve, and cardiac device-related infective endocarditis: a review and update on current innovative diagnostic and therapeutic strategies. Front Cell Dev Biol 2022; 10: 995508, https://doi.org/10.3389/fcell.2022.995508.
21. Thornhill M.H., Dayer M.J., Nicholl J., Prendergast B.D., Lockhart P.B., Baddour L.M. An alarming rise in incidence of infective endocarditis in England since 2009: why? Lancet 2020; 395(10233): 1325–1327, https://doi.org/10.1016/S0140-6736(20)30530-4.
22. Kobalava Z.D., Kotova E.O. Global and national trends in the evolution of infective endocarditis. Kardiologiia 2023; 63(1): 3–11, https://doi.org/10.18087/cardio.2023.1.n2307.
23. Reisinger M., Kachel M., George I. Emerging and re-emerging pathogens in valvular infective endocarditis: a review. Pathogens 2024; 13(7): 543, https://doi.org/10.3390/pathogens13070543.
24. Cai S., Yang Y., Pan J., Miao Q., Jin W., Ma Y., Zhou C., Gao X., Wang C., Hu B. The clinical value of valve metagenomic next-generation sequencing when applied to the etiological diagnosis of infective endocarditis. Ann Transl Med 2021; 9(19): 1490, https://doi.org/10.21037/atm-21-2488.
25. Kim S.L., Gordon S.M., Shrestha N.K. Distribution of streptococcal groups causing infective endocarditis: a descriptive study. Diagn Microbiol Infect Dis 2018; 91(3): 269–272, https://doi.org/10.1016/j.diagmicrobio.2018.02.015.
26. Chamat-Hedemand S., Dahl A., Østergaard L., Arpi M., Fosbøl E., Boel J., Oestergaard L.B., Lauridsen T.K., Gislason G., Torp-Pedersen C., Bruun N.E. Prevalence of infective endocarditis in streptococcal bloodstream infections is dependent on streptococcal species. Circulation 2020; 142(8): 720–730, https://doi.org/10.1161/CIRCULATIONAHA.120.046723.
27. Habib G., Lancellotti P., Erba P.A., Sadeghpour A., Meshaal M., Sambola A., Furnaz S., Citro R., Ternacle J, Donal E., Cosyns B., Popescu B., Iung B., Prendergast B., Laroche C., Tornos P., Pazdernik M., Maggioni A., Gale C.P.; EURO-ENDO Investigators. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Heart J Qual Care Clin Outcomes 2019; 5(3): 202–207, https://doi.org/10.1093/ehjqcco/qcz018. Erratum in: Eur Heart J Qual Care Clin Outcomes 2020; 6(1): 91, https://doi.org/10.1093/ehjqcco/qcz060.
28. Conwell M., Dooley J.S.G., Naughton P.J. Enterococcal biofilm — a nidus for antibiotic resistance transfer? J Appl Microbiol 2022; 132(5): 3444–3460, https://doi.org/10.1111/jam.15441.
29. Lecomte R., Laine J.B., Issa N., Revest M., Gaborit B., Le Turnier P., Deschanvres C., Benezit F., Asseray N., Le Tourneau T., Pattier S., Al Habash O., Raffi F., Boutoille D., Camou F. Long-term outcome of patients with nonoperated prosthetic valve infective endocarditis: is relapse the main issue? Clin Infect Dis 2020; 71(5): 1316–1319, https://doi.org/10.1093/cid/ciz1177.
30. Calderón-Parra J., Kestler M., Ramos-Martínez A., Bouza E., Valerio M., de Alarcón A., Luque R., Goenaga M.Á., Echeverría T., Fariñas M.C., Pericàs J.M., Ojeda-Burgos G., Fernández-Cruz A., Plata A., Vinuesa D., Muñoz P.; on behalf of the GAMES investigators. Clinical factors associated with reinfection versus relapse in infective endocarditis: prospective cohort study. J Clin Med 2021; 10(4): 748, https://doi.org/10.3390/jcm10040748.
31. Danneels P., Hamel J.F., Picard L., Rezig S., Martinet P., Lorleac’h A., Talarmin J.P., Buzelé R., Guimard T., Le Moal G., Brochard-Libois J., Beaudron A., Letheulle J., Codde C., Chenouard R., Boutoille D., Lemaignen A., Bernard L., Cattoir V., Dubée V; EFEMER study group. Impact of Enterococcus faecalis endocarditis treatment on risk of relapse. Clin Infect Dis 2023; 76(2): 281–290, https://doi.org/10.1093/cid/ciac777.
32. Basso M., Venditti C., Raponi G., Navazio A.S., Alessandri F., Giombini E., Nisii C., Di Caro A., Venditti M. A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit. Infect Drug Resist 2019; 12: 2391–2395, https://doi.org/10.2147/IDR.S206492.
33. Orme J., Rivera-Bonilla T., Loli A., Blattman N.N. Native valve endocarditis due to Ralstonia pickettii: a case report and literature review. Case Rep Infect Dis 2015; 2015: 324675, https://doi.org/10.1155/2015/324675.
34. Wright W.F. Central venous access device-related bacillus cereus endocarditis: a case report and review of the literature. Clin Med Res 2016; 14(2): 109–115, https://doi.org/10.3121/cmr.2016.1312.
35. Gopinathan A., Kumar A., Sen A.C., Sudha S., Varma P., Gs S., Eapen M., Dinesh K.R. A case series and review of bacillus cereus endocarditis from India. Open Microbiol J 2018; 12: 28–33, https://doi.org/10.2174/1874285801812010028.
36. Ioannou P., Miliara E., Baliou S., Kofteridis D.P. Infective endocarditis by Klebsiella species: a systematic review. J Chemother 2021; 33(6): 365–374, https://doi.org/10.1080/1120009X.2021.1888025.

Sinitskaya А.V., Kostunin А.Е., Khutornaya М.V., Poddubnyak А.О., Hryachkova О.N., Asanov М.А., Tupikin А.Е., Kabilov М.R., Stasev А.N., Sinitsky М.Y. 16S rRNA Metabarcoding Used to Identify the Etiology of Infective Endocarditis Agents. Sovremennye tehnologii v medicine 2026; 18(1): 45, https://doi.org/10.17691/stm2026.18.1.04